国产重组人乳头瘤病毒疫苗“馨可宁”获批上市

2020-01-01 佚名 国家药品监督管理局

国家药品监督管理局12月31日消息,近日,国家药品监督管理局批准厦门万泰沧海生物技术有限公司的双价人乳头瘤病毒疫苗(大肠杆菌)(商品名:馨可宁(Cecolin))上市注册申请,该药是首家获批的国产人乳头瘤病毒疫苗,适用于9-45岁女性。 人乳头瘤病毒(HPV)疫苗俗称宫颈癌疫苗,可用来预防女性宫颈癌和男、女生殖器癌以及生殖器疣。目前全球已上市的HPV疫苗有3种,分别是英国葛兰素史克公司生

国家药品监督管理局12月31日消息,近日,国家药品监督管理局批准厦门万泰沧海生物技术有限公司的双价人乳头瘤病毒疫苗(大肠杆菌)(商品名:馨可宁(Cecolin))上市注册申请,该药是首家获批的国产人乳头瘤病毒疫苗,适用于9-45岁女性。
 
人乳头瘤病毒(HPV)疫苗俗称宫颈癌疫苗,可用来预防女性宫颈癌和男、女生殖器癌以及生殖器疣。目前全球已上市的HPV疫苗有3种,分别是英国葛兰素史克公司生产的针对HPV16、18型的双价疫苗,美国默沙东公司生产的针对HPV6、11、16、18型的四价疫苗和针对HPV6、11、16、18、31、33、45、52、58型的九价疫苗。

此次获批的双价人乳头瘤病毒疫苗(大肠杆菌)系国内首家申报生产的HPV疫苗,针对HPV16、18型,被纳入国家重大新药创制专项支持。国家药监局按照《关于优化药品注册审评审批有关事宜的公告》等有关规定,将其纳入优先审评品种,加快批准其上市注册申请。本品的获批上市将进一步满足公众需求,提高产品的可及性。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2083311, encodeId=fd3e2083311cc, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Thu Sep 17 07:27:00 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632586, encodeId=4bc91632586c2, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88034, encryptionId=aa0488034a0, topicName=获批上市)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=820f21933891, createdName=weiz, createdTime=Sat Jun 20 09:27:00 CST 2020, time=2020-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443494, encodeId=4a281443494bc, content=<a href='/topic/show?id=4a65246327c' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24632, encryptionId=4a65246327c, topicName=人乳头瘤病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb15077773, createdName=ms3297076796458174, createdTime=Fri Jan 03 11:27:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490442, encodeId=e1e914904429a, content=<a href='/topic/show?id=87b22463ed6' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24637, encryptionId=87b22463ed6, topicName=人乳头瘤病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8128741577, createdName=hyf031, createdTime=Fri Jan 03 11:27:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2083311, encodeId=fd3e2083311cc, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Thu Sep 17 07:27:00 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632586, encodeId=4bc91632586c2, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88034, encryptionId=aa0488034a0, topicName=获批上市)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=820f21933891, createdName=weiz, createdTime=Sat Jun 20 09:27:00 CST 2020, time=2020-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443494, encodeId=4a281443494bc, content=<a href='/topic/show?id=4a65246327c' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24632, encryptionId=4a65246327c, topicName=人乳头瘤病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb15077773, createdName=ms3297076796458174, createdTime=Fri Jan 03 11:27:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490442, encodeId=e1e914904429a, content=<a href='/topic/show?id=87b22463ed6' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24637, encryptionId=87b22463ed6, topicName=人乳头瘤病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8128741577, createdName=hyf031, createdTime=Fri Jan 03 11:27:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2020-06-20 weiz
  3. [GetPortalCommentsPageByObjectIdResponse(id=2083311, encodeId=fd3e2083311cc, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Thu Sep 17 07:27:00 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632586, encodeId=4bc91632586c2, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88034, encryptionId=aa0488034a0, topicName=获批上市)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=820f21933891, createdName=weiz, createdTime=Sat Jun 20 09:27:00 CST 2020, time=2020-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443494, encodeId=4a281443494bc, content=<a href='/topic/show?id=4a65246327c' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24632, encryptionId=4a65246327c, topicName=人乳头瘤病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb15077773, createdName=ms3297076796458174, createdTime=Fri Jan 03 11:27:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490442, encodeId=e1e914904429a, content=<a href='/topic/show?id=87b22463ed6' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24637, encryptionId=87b22463ed6, topicName=人乳头瘤病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8128741577, createdName=hyf031, createdTime=Fri Jan 03 11:27:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2083311, encodeId=fd3e2083311cc, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Thu Sep 17 07:27:00 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632586, encodeId=4bc91632586c2, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88034, encryptionId=aa0488034a0, topicName=获批上市)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=820f21933891, createdName=weiz, createdTime=Sat Jun 20 09:27:00 CST 2020, time=2020-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443494, encodeId=4a281443494bc, content=<a href='/topic/show?id=4a65246327c' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24632, encryptionId=4a65246327c, topicName=人乳头瘤病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb15077773, createdName=ms3297076796458174, createdTime=Fri Jan 03 11:27:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490442, encodeId=e1e914904429a, content=<a href='/topic/show?id=87b22463ed6' target=_blank style='color:#2F92EE;'>#人乳头瘤病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24637, encryptionId=87b22463ed6, topicName=人乳头瘤病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8128741577, createdName=hyf031, createdTime=Fri Jan 03 11:27:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]

相关资讯

NEJM:一例阴茎鳞状细胞癌,HPV也同样对男性致癌

男性,54岁,因阴茎龟头右侧出现一个息肉样肿块大约8个月余而来院就诊。经体格检查,从病灶部位可见明显的化脓性分泌物。同时,右侧腹股沟淋巴结可触及明显的肿大。在过去的6个月内,他的体重减轻了9公斤。据该男子主诉,在过去他曾与多名性伴侣发生过无保护性的性行为。血清学检测结果显示各种性病感染阴性,其中包括人类免疫缺陷病毒感染。病灶部位和淋巴结肿大处分别去活体组织检查,结果显示为鳞状细胞癌与人乳头瘤病毒感

CLIN CANCER RES:头颈部肿瘤中人乳头瘤病毒调节HER3表达

人乳头瘤病毒(HPV)16在头颈部鳞状细胞癌(HNSCC)中具有病因学作用,同时病毒表达的E6和E7癌蛋白是肿瘤生长所必须的物质。HPV+肿瘤患者预后更好,但是目前尚缺乏HPV特异性治疗方式。近期研究发现HPV+肿瘤与HPV-肿瘤受体络氨酸激酶(RTK)不同。HER3就是这些RTK中的一种,HER3在HPV+肿瘤中高表达且与PI3K作用。CLIN CANCER RES近期发表了一篇文章,研究HPV

NEJM:扁桃体癌-病例报道

并非所有患有原发性扁桃体癌的患者都有明显的病变;肿瘤可能隐藏在扁桃体隐窝中。该患者开始接受化学疗法和免疫疗法,然后手术切除癌症和颈部解剖,避免了放射治疗。

新型CDK9小分子靶向药物FIT-039,有望治疗宫颈癌

京都大学的一个研究小组已开始对宫颈上皮内瘤变患者进行治疗,目的是在安全性和有效性得到确认的情况下,在三年内将其商品化。

盘点:为何随着年龄增加 机体患癌的风险会越来越大?

如今在澳大利亚,二分之一的男性以及三分之一的女性在85岁之前都会被诊断为某种类型的癌症,而且让我们更为担忧的是,所使用的统计学数据并不包含最为常见的皮肤癌症,比如皮肤基底细胞癌和皮肤鳞状细胞癌,据估计每年有成千上万的澳大利亚人都会接受癌症治疗。 在过去三十年里新发癌症患者的数量不断增加,在澳大利亚,1982年每年有47445名新发

JAMA Oncol:人乳头瘤病毒(HPV)-16大大增加了口咽部鳞癌的风险

一项新的研究表明,在口腔中检测到人乳头瘤病毒(HPV)-16使得口咽鳞癌的风险增加了22倍。由纽约爱因斯坦医学院,医学博士,理学博士, Ilir Agalliu和共同作者的研究还报道了其他通常在皮肤检测到的口腔HPVs与头颈部鳞状细胞癌(HNSCC)的风险正相关,这表明在HNSCC中HPV的作用可能比目前公认的更重要。该研究在96650名参与者中进行,这些参与者来自两个大的研究小组,他们在基线时没